ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $45,000 | +221.4% | 3,080 | -42.1% | 0.00% | – |
| Q2 2020 | $14,000 | +40.0% | 5,318 | -38.1% | 0.00% | – |
| Q4 2019 | $10,000 | +66.7% | 8,598 | +49.6% | 0.00% | – |
| Q3 2019 | $6,000 | -33.3% | 5,747 | +3.6% | 0.00% | – |
| Q2 2019 | $9,000 | +50.0% | 5,547 | +256.3% | 0.00% | – |
| Q1 2019 | $6,000 | +200.0% | 1,557 | +72.4% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 903 | +103.8% | 0.00% | – |
| Q3 2018 | $3,000 | -50.0% | 443 | -53.5% | 0.00% | – |
| Q2 2018 | $6,000 | +20.0% | 952 | +91.9% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 496 | -6.6% | 0.00% | – |
| Q4 2017 | $4,000 | -60.0% | 531 | -40.9% | 0.00% | – |
| Q3 2017 | $10,000 | -23.1% | 899 | -22.2% | 0.00% | – |
| Q2 2017 | $13,000 | +62.5% | 1,156 | +50.5% | 0.00% | – |
| Q1 2017 | $8,000 | -46.7% | 768 | -39.7% | 0.00% | – |
| Q4 2016 | $15,000 | -11.8% | 1,274 | -7.0% | 0.00% | – |
| Q3 2016 | $17,000 | +112.5% | 1,370 | +101.2% | 0.00% | – |
| Q2 2016 | $8,000 | -92.8% | 681 | -92.2% | 0.00% | – |
| Q1 2016 | $111,000 | – | 8,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
| Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
| Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
| Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
| Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
| Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |